Nemaura Medical Overview
Valuation check: NMRD's P/S ratio is 0.0, below the Healthcare sector average of 6.41.
Get informed when a big investor buys or sells
+ Follow-0.00
Price-to-Sales ratio compares a company's stock price to its revenue per share. A lower P/S ratio may indicate that the stock is undervalued relative to its sales.
Nemaura Medical (NMRD) currently reports a P/S ratio of 0.0. That is below the Healthcare sector average of 6.41. Use the charts on this page to explore Nemaura Medical's P/S ratio history and peer comparisons.
Nemaura Medical's P/S ratio of 0.0 is lower than the Healthcare sector average of 6.41. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/S ratio is a valuation multiple that relates Nemaura Medical's market price to a fundamental measure such as earnings, sales, or book value. At 0.0, NMRD can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/S ratio of 0.0, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 6.41. From there, open related valuation or income-statement pages for Nemaura Medical, and consider following NMRD for alerts when major investors trade the stock.
Nemaura Medical is classified in the Healthcare sector. On P/S ratio, it currently shows 0.0 versus a sector average near 6.41. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NMRD with unrelated industries.
